On October 9, 2023, Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd closed the transaction. The company amended the terms of the transaction and issued 935,2740 A shares at a price of CNY 32.29 per share for the gross proceeds of CNY 301,999,975. The net proceeds will be CNY 294,836,293 after the issuance expense of CNY 7,163,682.37.